Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save this grant
Crystal ball icon
Predicted Deadline
The next cycle for this opportunity is predicted based on past data. If you save this grant, we’ll notify you if there are any changes.

Next predicted deadline: Oct 21, 2023 (Letter of inquiry)

Later predicted deadlines: Nov 21, 2023 (Full proposal), Nov 21, 2023 (Letter of inquiry), Dec 21, 2023 (Full proposal), Jan 21, 2024 (Letter of inquiry), Feb 21, 2024 (Full proposal), Mar 18, 2024 (Letter of inquiry), Apr 18, 2024 (Full proposal), Jun 22, 2024 (Letter of inquiry), Jul 19, 2024 (Letter of inquiry), Jul 22, 2024 (Full proposal), Aug 19, 2024 (Full proposal), Oct 21, 2024 (Letter of inquiry), Nov 20, 2024 (Letter of inquiry), Nov 21, 2024 (Full proposal), Dec 20, 2024 (Full proposal)

Grant amount: Up to US $1,000,000

Fields of work: Medical Technology & Devices Cardiovascular Diseases & Systems Respiratory Diseases & Systems Hematological Systems Sleep

Applicant type: Government Entity, Nonprofit, For-Profit Business, Indigenous Group

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico Show all


NOTE: All types of non-AIDS applications allowed for this funding opportunity announcement are due by 5:00 PM local time of applicant organization on these dates:

  • November 21, 2022
  • February 21, 2023 
  • July 21, 2023
  • November 21, 2023
  • February 21, 2024
  • July 22, 2024
  • November 21, 2024

All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due by 5:00 PM local time of applicant organization on these dates:

  • December 21, 2022
  • April 18, 2023
  • August 18, 2023
  • December 21, 2023
  • April 18, 2024
  • August 19, 2024
  • December 20, 2024

This Catalyze Product Definition Funding Opportunity Announcement (FOA) will provide the early stage translational support needed to develop and test device prototype designs, identify diagnostic disease targets and develop associated assays, and develop research tools for use in the treatment of HLBS diseases and disorders. This FOA is part of a suite of Catalyze innovation grants to advance projects to the point where they can meet the entry criteria for the NHLBI Catalyze Preclinical program or attract independent development support from other federal or private partners for preclinical product optimization and characterization.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed May 09, 2023 and last updated May 09, 2023